Developing blood-based biomarkers for early diagnosis of Alzheimer's disease
Aβ42 and t-tau: An immunomagnetic reduction assay in a small study of patients with mild cognitive impairment indicated that elevated plasma Aβ42 and t-tau levels are related to later cognitive decline.
References：Chen T et al, Plasma Aβ42 and Total Tau Predict Cognitive Decline in Amnestic Mild Cognitive Impairment, Nature Sci Rep 9(1): p13,984, 2019
https://www.news-medical.net/whitepaper/20210722/Research-shows-non-inva...
